Ben Fensterheim, MD, PhD
Ben hails from Rockville, MD. He earned his PhD in the Sherwood Lab in August 2017 studying how a single administration of TLR ligands can prevent infections for over two weeks. His work centered on the role of the macrophage in this protection, and how TLR ligands persistently change macrophage metabolism to fuel an antimicrobial state. He is currently a pediatric resident physician at the Children's Hospital of Philadelphia and plans to start a fellowship in neonatology in 2021.